{"id":2,"date":"2017-03-20T11:52:07","date_gmt":"2017-03-20T10:52:07","guid":{"rendered":"http:\/\/scholar.semmelweis.hu\/igazpeter\/cv\/"},"modified":"2025-11-18T13:37:31","modified_gmt":"2025-11-18T12:37:31","slug":"cv","status":"publish","type":"page","link":"https:\/\/scholar.semmelweis.hu\/igazpeter\/cv\/","title":{"rendered":"CV"},"content":{"rendered":"

Qualifications: \u00a0\u00a0\u00a0\u00a0\u00a0<\/h3>\n
    \n
  1. Physician, MD (1997)<\/li>\n
  2. PhD (1999)<\/li>\n
  3. Biologist, MSc (specialisation: molecular biology) (1999)<\/li>\n
  4. Board certificate in internal medicine (2002)<\/li>\n
  5. Jurist, JD (2005)<\/li>\n
  6. Board certificate in endocrinology (2005)<\/li>\n
  7. Board certificate in clinical genetics (2008)<\/li>\n
  8. \n

    Board certificate in clinical oncology (2024)<\/p>\n<\/li>\n

  9. European Board Examination in Endocrinology, Diabetology and Metabolism (EBEEDM) (2019)<\/li>\n
  10. Habilitation (internal medicine, Semmelweis University) (2012)<\/li>\n
  11. Doctor of the Hungarian Academy of Sciences (DSc) (2013)<\/li>\n<\/ol>\n

    \u00a0 My 10 major scientific results since obtaining the PhD degree:<\/h3>\n
      \n
    1. Exploration of the cytokine and cytokine receptor expression pattern of hypothalamic GnRH neurons and the functional role of oncostatin M (results of my study trip in Switzerland)<\/li>\n
    2. Description of microRNA expression of adrenocortical and adrenomedullary tumors among the first world-wide<\/li>\n
    3. Novel tissue and circulating microRNA markers of adrenal tumors, and identification of novel circulating microRNA markers for adrenocortical malignancy and primary aldosteronism.<\/li>\n
    4. The first functional genomics meta-analysis on adrenocortical tumors<\/li>\n
    5. Raising the potential novel treatment option of 9-cis retinoic acid in adrenocortical cancer<\/li>\n
    6. Showing the relevance of histamine in adrenocortical tumors<\/li>\n
    7. Novel genetic polymorphisms by in silico<\/em> approaches<\/li>\n
    8. Description of novel clinical phenotypes of multiple endocrine neoplasia type 2<\/li>\n
    9. Novel hypotheses on the biological relevance of circulating microRNAs (a. circulating microRNAs as tumor suppressors, b. tissue specific action of microRNA as a defense mechanism against circulating microRNA)<\/li>\n
    10. Showing the efficacy of somatostatin peptide radionuclide treatment among the neuroendocrine tumor patients of 2nd<\/sup> Department of Medicine<\/li>\n<\/ol>\n

      \u03a3 Impact Factor (by the IF-s in the year of publication):\u00a0<\/h3>\n
      \n
      Scientometric data:<\/h5>\n
        \n
      • \n

        \u03a3 Impact Factor (\u03a3IF): 455.227,\u00a0\u03a3IF of first- and last-authored journal articles: 206.905,\u00a0\u03a3IF of original manuscripts: 323.001<\/p>\n<\/li>\n

      • \n

        \u03a3IF of first- and last-authored original journal articles: 121.783<\/p>\n<\/li>\n

      • \n

        H-index Web of Science: 28, Scopus: 29\u00a0(H-index Google Scholar: 36)<\/p>\n<\/li>\n<\/ul>\n<\/div>\n

        My 7 PhD students who have already been awarded the PhD:<\/h3>\n
          \n
        • \n

          Dr. Peter M\u00e1rton Szab\u00f3 MD PhD 2011 <\/strong>(Title of Dissertation: Exploring the molecular patomechanism of adrenocortical tumors, <\/span>Hungarian: <\/em>A mell\u00e9kvesek\u00e9reg-daganatok molekul\u00e1ris patogenezis\u00e9nek vizsg\u00e1lata<\/em>)<\/span><\/p>\n<\/li>\n

        • \n

          Dr. Zs\u00f3fia T\u00f6mb\u00f6l MD PhD 2011 <\/strong>(Title of Dissertation: Exploring the expression patterns and pathogenic relevance of microRNAs in adrenal tumours, Hungarian: <\/em>MikroRNS-ek expresszi\u00f3s mint\u00e1zat\u00e1nak \u00e9s patogenetikai szerep\u00e9nek vizsg\u00e1lata a mell\u00e9kvese daganataiban<\/em>)<\/p>\n<\/li>\n

        • \n

          Dr. Zsippai Adrienn PhD 2013<\/strong> (Title of Dissertation: Analysis of the effects of mitotane on gene expression and the pathways affected by microRNAs in adrenocortical carcinoma; Hungarian: A mitot\u00e1n g\u00e9nexpresszi\u00f3s hat\u00e1sainak \u00e9s a mikroRNS-ek \u00e1ltal befoly\u00e1solt \u00fatvonalak vizsg\u00e1lata mell\u00e9kvesek\u00e9reg carcinom\u00e1ban)<\/em> \u00a0<\/p>\n<\/li>\n

        • \n

          Dr. Zolt\u00e1n Nagy MD PhD 2017<\/strong> Title of Dissertation:\u00a0<\/strong>Antitumoral effects of 9-cis retinoic acid and mitotane and evaluation of microRNAs in adrenocortical\u00a0cancer xenograft models; Hungarian: A 9-cisz retinsav \u00e9s a mitot\u00e1n tumorellenes hat\u00e1sainak \u00e9s a mikroRNS-ek vizsg\u00e1lata mell\u00e9kvesek\u00e9reg-r\u00e1k xenograft modelljein\u00a0<\/em>\u00a0<\/p>\n<\/li>\n

        • \n

          Dr. <\/strong>P\u00e1l <\/strong>Perge\u00a0 MD PhD 2018<\/strong> Title of Dissertation:<\/strong> Evaluation of circulating extracellular vesicle-associated microRNAs in patients with adrenocortical tumors; Hungarian; Kering\u0151 extracellul\u00e1ris vezikula-asszoci\u00e1lt mikroRNS-ek expresszi\u00f3j\u00e1nak vizsg\u00e1lata mell\u00e9kvesek\u00e9reg-daganatban szenved\u0151 betegekben<\/em><\/p>\n<\/li>\n

        • \n

          Dr. \u00c1bel Decmann MD PhD 2020 <\/strong> Title of Dissertation:<\/strong> Analysis of circulating microRNAs in the benign and malignant adrenal tumors Hungarian; Kering\u0151 mikroRNS-ek vizsg\u00e1lata j\u00f3- \u00e9s rosszindulat\u00fa mell\u00e9kvese daganatokban<\/em> \u00a0<\/p>\n<\/li>\n

        • \n

          Dr. Peter I Turai MD- PhD 2023\u00a0<\/strong>[Investigation of non-coding tissue RNAs in benign and malignant adrenal cortex tumors ]\u00a0Hungarian; Nem k\u00f3dol\u00f3 sz\u00f6veti RNS-ek vizsg\u00e1lata j\u00f3- \u00e9s rosszindulat\u00fa mell\u00e9kvesek\u00e9reg daganatokban<\/em><\/p>\n<\/li>\n<\/ul>\n

          \n

          Current PhD student:<\/strong> Dr. Balint V\u00e9kony<\/p>\n<\/div>\n

          Research projects supervised as Principal Investigator:<\/h3>\n
            \n
          1. ETT<\/strong> \u201eFunkcion\u00e1lis genomikai vizsg\u00e1latok a mell\u00e9kvesek\u00e9reg daganatainak patogenezis\u00e9ben \u2013 k\u00fcl\u00f6n\u00f6s tekintettel a citokinek \u00e9s receptoraik expresszi\u00f3j\u00e1ra\u201d (Functional genomics studies on the pathogenesis of adrenocortical tumours \u2013 focusing ont he expression of cytokines and cytokine receptors<\/em>) 2006-2008 \u2013 ETT 089\/2006<\/strong><\/li>\n
          2. Semmelweis University Research Fund<\/strong> \u201dFunkcion\u00e1lis genomikai vizsg\u00e1latok a mell\u00e9kvesek\u00e9reg daganatok patogenezis\u00e9nek vizsg\u00e1lat\u00e1ban, k\u00fcl\u00f6n\u00f6s hangs\u00fallyal az immunrendszeri medi\u00e1torok szerep\u00e9nek vizsg\u00e1lat\u00e1ra.\u201d (Studies on the pathogenesis of adrenocortical tumours by functional.genomics approaches, focusing on the expression of cytokines and their receptors<\/em>) 2006<\/li>\n
          3. OTKA PD project 2008-2010<\/strong> \u201eFunkcion\u00e1lis genomikai, mikroRNS \u00e9s feh\u00e9rje szint\u0171 vizsg\u00e1latok sporadikus mell\u00e9kvese daganatokban, gy\u00f3gyszeresen befoly\u00e1solhat\u00f3 patomechanizmusok felder\u00edt\u00e9s\u00e9re. (Functional genomics, microRNA and protein level studies on sporadic adrenal tumor pathogenesis in search for novel pathomechanisms.<\/em>)\u201d PD72306 \u2013 scoring: 9 (excellent)<\/strong><\/li>\n
          4. OTKA K project<\/strong> 2012-2015.\u00a0 \u201eGy\u00f3gyszeresen befoly\u00e1solhat\u00f3 patomechanizmusok vizsg\u00e1lata a mell\u00e9kvesek\u00e9reg, mell\u00e9kvesevel\u0151 \u00e9s m\u00e1s endokrin szervek daganataiban\u201d (Search for druggable pathomechanisms in adrenocortical, adrenomedullary and other endocrine tumors<\/em>) K100295 \u2013 scoring: 10 (excellent)<\/strong><\/li>\n
          5. OTKA (NKFIH) K project<\/strong> 2015-2019. \u201eKering\u0151 mikroRNS-ek \u00e9s extracellul\u00e1ris vezikul\u00e1k vizsg\u00e1lata a mell\u00e9kvese-daganatok diagn\u00f3zis\u00e1ban\u201d (Studies on circulating microRNA and extracellular vesicles for the diagnosis of adrenal tumours<\/em>) K115398<\/strong><\/li>\n
          6. OTKA (NKFIH) K project 2020-2024<\/strong> “Studies on non-coding RNA in endocrine tumors” K134215<\/strong><\/li>\n
          7. OTKA (NKFIH) K project<\/strong> (2024-2028)<\/strong> “Search for treatment predictive molecular biomarkers in endocrine tumors by the help of artificial intelligence”<\/li>\n<\/ol>\n

            Languages spoken:<\/h3>\n